Literature DB >> 18587018

Mantle cell lymphoma lacking the t(11;14) translocation: a case report and brief review of the literature.

K E Hunt1, K K Reichard, C S Wilson.   

Abstract

The diagnosis of mantle cell lymphoma (MCL) requires a multifaceted approach with integration of morphology and immunophenotype, supported by cyclin D1 positivity or identification of t(11;14)(q13;q32). Interphase fluorescence in situ hybridisation (FISH) using a dual colour, dual fusion probe strategy for t(11;14) is a rapid test with high sensitivity and specificity for MCL, and is easily performed on routine bone marrow aspirate or peripheral blood specimens. This test has become the method of choice for many pathologists to confirm a diagnosis of MCL. This report describes a case of MCL with a normal (negative) FISH signal pattern for t(11;14) that was found to be cyclin D1 positive by immunohistochemistry in tissue sections. This case illustrates the need for additional testing when the t(11;14) abnormality is not identified but the morphology and immunophenotype are otherwise suggestive of MCL.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18587018     DOI: 10.1136/jcp.2007.048629

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  3 in total

1.  Primary mantle cell lymphoma of the trachea.

Authors:  Achuta K Guddati; Creticus P Marak
Journal:  Med Oncol       Date:  2012-03-06       Impact factor: 3.064

2.  Solitary primary gastric mantle cell lymphoma.

Authors:  Chang Ha Kim; Hoon Jai Chun; Tae Hyung Kim; Wonho Jung; Sunwon Kim; Jong Jin Hyun; Bora Keum; Yeon Seok Seo; Yong Sik Kim; Yoon Tae Jeen; Hong Sik Lee; Soon Ho Um; Chang Duck Kim; Ho Sang Ryu; Insun Kim
Journal:  Gut Liver       Date:  2011-11-21       Impact factor: 4.519

3.  Mantle cell lymphoma negative for t(11,14) involving the kidneys: a case report.

Authors:  Hasan Nassereldine; Razan Mohty; Hussein Awada; Iman Abou Dalle; Jean El-Cheikh; Ali Bazarbachi
Journal:  J Med Case Rep       Date:  2022-06-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.